Abstract
Venetoclax (ABT-199) and idasanutlin (RG7388) are efficient anticancer drugs targeting two essential apoptosis markers, Bcl-2 and MDM2, respectively. Recent studies have shown that the combination of these two drugs leads to remarkable enhancement of anticancer efficacy, both in vitro and in vivo. In an attempt to disclose the relationships of their protein targets, competitive affinity-based proteome profiling coupled with bioimaging was employed to characterize their protein targets in the same cancer cell line and tumor tissue. A series of protein hits, including ITPR1, GSR, RER1, PDIA3, Apoa1, and Tnfrsf17 were simultaneously identified by pull-down/LC-MS/MS with the two sets of affinity-based probes. Dual imaging was successfully carried out, with the simultaneous detection of Bcl-2 and MDM2 expression in various cancer cells. This could facilitate the novel diagnostic and therapeutic strategies of dual targeting of Bcl-2/MDM2.
References
Jul 21, 2004·The Journal of Cell Biology·Rui ChenClark W Distelhorst
May 12, 2009·Physiology & Behavior·Peter G BradfordBrian G Chrzan
Jan 8, 2011·Journal of the American Chemical Society·Ji-Hyang HaSeung-Wook Chi
Jan 8, 2013·Nature Medicine·Andrew J SouersSteven W Elmore
Feb 19, 2013·Angewandte Chemie·Slava ZieglerHerbert Waldmann
Jun 12, 2013·Angewandte Chemie·Zhengqiu LiShao Q Yao
Jul 3, 2013·Journal of Medicinal Chemistry·Qingjie DingBradford Graves
May 24, 2014·Acta histochemica·Marian AdamkovPeter Kružliak
Jun 20, 2014·Molecular & Cellular Proteomics : MCP·Jürgen CoxMatthias Mann
Jun 28, 2014·Journal of the American Chemical Society·Zhengqiu LiShao Q Yao
Oct 22, 2014·Bioconjugate Chemistry·Randy J GiedtRalph Weissleder
Nov 15, 2014·Journal of Medicinal Chemistry·Yujun ZhaoShaomeng Wang
Sep 24, 2015·Cancer Chemotherapy and Pharmacology·Apostolia-Maria Tsimberidou
Nov 14, 2015·Angewandte Chemie·Axel PahlStephan A Sieber
Nov 19, 2015·Natural Product Reports·Sijun PanShao Q Yao
Dec 8, 2015·Angewandte Chemie·Zhengqiu LiShao Q Yao
Mar 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric SanchezJames R Berenson
Mar 17, 2016·Journal of Medicinal Chemistry·Ziqian WangZhichao Zhang
Jun 30, 2016·Journal of Hematology & Oncology·Christian LehmannMarkus Dangl
Nov 23, 2016·Angewandte Chemie·Pier Luca D'AlessandroAmanda Cobos-Correa
Dec 30, 2016·Future Science OA·Da-Yong LuJian Ding
Jan 24, 2017·Cell·Christopher G ParkerBenjamin F Cravatt
Jun 24, 2017·Nature Reviews. Cancer·Miles A Miller, Ralph Weissleder
Sep 17, 2017·Oncotarget·Alan Van GoethemTom Van Maerken
Dec 13, 2017·Cancer Cell·Rongqing PanMichael Andreeff
Jun 14, 2017·MedChemComm·Haijun Guo, Zhengqiu Li
Aug 16, 2018·MedChemComm·Tingting LiuMinyong Li
Citations
Jun 26, 2018·Chemistry, an Asian Journal·Binbin ZhengZhengqiu Li
Aug 23, 2018·Chembiochem : a European Journal of Chemical Biology·Ziqian WangZhichao Zhang
Jan 19, 2019·Chemical Communications : Chem Comm·Wenyan LiuZhengqiu Li
Mar 1, 2019·Organic & Biomolecular Chemistry·Wenjie LangJingyan Ge
Apr 4, 2019·Chembiochem : a European Journal of Chemical Biology·Yu ChangZhengqiu Li
Nov 26, 2019·Chemistry, an Asian Journal·Jiaqian XuZhengqiu Li
Dec 24, 2018·Chemical Communications : Chem Comm·Cuiping GuoZhengqiu Li
Sep 4, 2020·Chembiochem : a European Journal of Chemical Biology·Xiaodong ZhangZhichao Zhang
Dec 29, 2020·Cell Chemical Biology·Jaeyoung HaSeung Bum Park
Mar 12, 2020·Journal of the American Chemical Society·Nan MaZhengqiu Li
Aug 14, 2021·Acta Pharmaceutica Sinica. B·Chenglong GaoTao Pang
Nov 20, 2019·ACS Chemical Biology·Nan MaZhengqiu Li
Apr 16, 2020·ACS Medicinal Chemistry Letters·Jiaqian XuZhengqiu Li
Sep 11, 2021·Biological Chemistry·Congzhen ShenZhengqiu Li
Sep 16, 2021·Molecular Pharmaceutics·Zhengyuan ZhouSatish K Chitneni
Oct 9, 2021·Journal of Medicinal Chemistry·Youlong FanZhengqiu Li
Nov 30, 2021·Analytical Chemistry·Duoduo ZhangSongqin Liu
Dec 31, 2021·Organic Letters·Chuan WanZigang Li